Recombinant EIF4A1 anticorps
Aperçu rapide pour Recombinant EIF4A1 anticorps (ABIN7127468)
Antigène
Voir toutes EIF4A1 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Réactivité croisée
- Humain
-
Purification
- Affinity-chromatography
-
Immunogène
- A synthesized peptide derived from human eIF4A1
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: WB:1:500-1:5000, IF:1:20-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- EIF4A1 (Eukaryotic Translation Initiation Factor 4A1 (EIF4A1))
-
Autre désignation
- EIF4A1
-
Sujet
-
Background: ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon.
Aliases: Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1), EIF4A1, DDX2A EIF4A
-
UniProt
- P60842
Antigène
-